Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”It was an exciting week presenting work from laboratory at the International Proteolysis Society’s 13th Biannual Meeting in Buzios, Rio de Janeiro, Brazil.”
The International Proteolysis Society’s 13th Biannual Meeting , held in Búzios, Brazil, from October 26–30, 2025, offered an excellent opportunity for scholars and researchers to gather and engage in meaningful discussions on a wide range of topics.
The meeting also served as a valuable platform for networking and building important professional connections within the research community.
At the meeting Joshua Muia presented research from the Versiti Blood Research Institute laboratory on genetic alterations affecting ADAMTS13 maturation.
Stay updated with Hemostasis Today.
-
Dec 16, 2025, 16:56Kathryn Mikkelsen on The Beat: Vasculearn Network’s Newsletter for Clot Survivors
-
Dec 16, 2025, 16:50Raul Santos on Sex-Specific Biology and Plasma Fructose Levels in Cardiovascular Risk
-
Dec 16, 2025, 16:34Mads Krogsgaard Thomsen on Novo Nordisk Haemophilia Foundation’s Support for Haemoglobinopathies
-
Dec 16, 2025, 16:22Leonardo Furtado Freitas Presents a Rare Hemorrhagic Hemangioblastoma Case
-
Dec 16, 2025, 16:14Nicolas Gendron on Sustainability in Anticoagulation and DOACs
-
Dec 16, 2025, 15:39Reza Shojaei: Every Expired Unit of Blood Tells a Story
-
Dec 16, 2025, 14:03Francesco Lo Monaco on Rethinking Blood Pressure: The Major Problem with How We Understand It
-
Dec 16, 2025, 14:03Marilena Vrana Urges EU Policymakers to “Keep Patients at the Centre” of Critical Medicines Act
-
Dec 16, 2025, 14:02Even Distribution of Protective Hemoglobin Prevents Sickle Cell Symptoms